Findings
BPD, death
SECONDARY
In this secondary analysis of a randomized clinical trial including 799 extremely preterm infants, baseline risk for grades 2 to 3 BPD or death estimated using infants’ gestational age, birth weight, sex, respiratory support, and fraction of inspired oxygen was not associated with either benefit or harm from hydrocortisone exposure.